by APFLI | Jun 9, 2005 | Birth Control Archive
New York State Senate Rules in Favor of EC at Any Age New Hampshire Makes the Morning After Pill (EC) More Available Study: The Pill May Cause Permanent Loss of Sex Drive Male Contraceptive Pill Concern About Spermicide Nonoxynol-9 Continues to Increase...
by APFLI | Mar 12, 2005 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
Doctors at the Mount Sinai School of Medicine have tested a gel that when applied topically in the vagina, may help prevent infection by both H.I.V. and herpes simplex virus. AIDS researchers have long sought such a microbicide. The effectiveness of the gel, called...
by APFLI | Jan 28, 2005 | Barrier Methods
During the XIII International AIDS Conference held in Durban, South Africa, July 2000, researchers from the Joint United Nations Program on AIDS (UNAIDS) presented results of a study of a product, COL-1492,* which contains nonoxynol-9 (N-9) (1). N-9 products are...
by APFLI | Oct 13, 2004 | Birth Control Archive
Depo Provera May Triple STD Risk Research on Experimental Anti-AIDS Gel Dropped by British Lab Depo Provera Increases Chance of Chlamydia, GonorrheaWomen who use the injected contraceptive Depo-Provera have a higher rate of sexually transmitted...
by APFLI | Mar 9, 2004 | Birth Control Archive
ORAL CONTRACEPTIVES CONTAINING CYPROTERONE INCREASE RISK OF DEEP VEIN THROMBOSIS: four times more likely to develop deep vein thrombosis, or venous blood clots, than those taking OCs that contain levonorgestrel. Deep vein thrombosis can cause potentially fatal...
